By Cecilia Butini
Siemens Healthineers AG on Wednesday set revenue and earnings-per-share growth targets for fiscal years 2023 to 2025 as it launched the third phase of its strategy through 2025.
The German medical-equipment maker said it expects revenue growth of 6% to 8% annually for fiscal years 2023 to 2025, while adjusted earnings-per-share growth is expected at 12% to 15% a year based on broad-based margin expansion.
The goals are part of the latest phase of the company’s strategy, which begins in fiscal year 2022 after Siemens Healthineers said it completed the previous plan a year ahead of schedule.
Siemens Healthineers said it expects research-and-development spending at 8% to 9% of revenue, and selling, general and administrative expenses at 15% to 17%.
Synergy targets from the acquisition of Varian are going to be raised to more than 350 million euros ($396.3 million) by 2025, according to the company. It added that it will partially reinvest cost synergies to generate future revenue synergies, and that those will be effective to profit-and-loss primarily in fiscal 2024 and 2025.
Write to Cecilia Butini at cecilia.butini@wsj.com
This article was originally published by Marketwatch.com. Read the original article here.
